In a hospital setting, it is common to encounter certain haematological emergencies irrespective of whether or not the patient has an underlying haematological condition or if the hospital has a well-established haematology service. This article aims to define and illustrate common and less common haematological emergencies that a physician may encounter on the wards and the appropriate initial management for the patient prior to a formal hematological consult.
HowardSCJonesDPPuiCH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844–54 doi: 10.1056/NEJMra0904569.
2.
MontesinosPLorenzoIMartinGSanzJPerez-SirventMLMartinezD. Tumor lysis syndrome in patients with acute myeloid leukemia: Identification of risk factors and development of a predictive model. Haematologica2008;93(1):67–74 doi: 10.3324/haematol.11575.
3.
CoiffierBAltmanAPuiCHYounesACairoMS. Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review. J Clin Oncol2008;26(16):2767–78 doi: 10.1200/JCO.2007.15.0177.
4.
Abu-AlfaAKYounesA. Tumor lysis syndrome and acute kidney injury: Evaluation, prevention, and management. Am J Kidney Dis2010;55(5Suppl 3):S1–13; quiz S14–9 doi: 10.1053/j.ajkd.2009.10.056.
5.
MertenGJBurgessWPGrayLVHollemanJHRoushTSKowalchukGJ. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA2004;291(19):2328–34 doi: 10.1001/jama.291.19.2328.
6.
CongerJDFalkSA. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest1977;59(5):786–93 doi: 10.1172/JCI108700.
7.
ZukermanTGanzelCTallmanMSRoweJM. How I treat hematologic emergencies in adults with acute leukemia. Blood2012;120(10):1993–2002 doi: 10.1182/blood-2012-04-424440.
8.
ZojerNLudwigH. Hematological emergencies. Ann Oncol2007;18(Suppl 1):i45–8 doi: 10.1093/annonc/mdl450.
9.
Department of Haematology, Singapore General Hospital (SG). Aide Memoire for the Haematology Medical Officer. 7th edition. Singapore: Singapore General Hospital; 2011.
10.
Blood Services Group, Health Sciences Authority (SG). Common restructured hospital massive transfusion protocol. Singapore: Health Sciences Authority; 2011.
11.
FrewinR. ABC of clinical haematology: Haematological emergencies. BMJ1997;314(7090):1333–6 doi: 10.1136/bmj.314.7090.1333.
12.
Australian Red Cross Blood Service. Adverse events. [Internet] [updated 2014 Feb 7; cited 2014 Mar 19] Australia: Australian Red Cross. Available from: http://www.transfusion.com.au/adverse_events.
13.
De BottonSDombretHSanzMMiguelJSCaillotDZittounR. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood1998;92(8):2712–8.
14.
FrankelSREardleyALauwersGWeissMWarrellRPJr. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med1992;117(4):292–6.
15.
TallmanMSAndersenJWSchifferCAAppelbaumFRFeusnerJHOgdenA. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood2000; 95(1):90–5.
CamachoLHSoignetSLChanelSHoRHellerGScheinbergDA. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol2000;18(13):2620–5.
18.
MontesinosPBerguaJMVellengaERayonCParodyRde la SernaJ. Differentiation syndrome in patients with acute promyelocytic leukemia treated with alltrans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors. Blood2009;113(4):775–83 doi: 10.1182/blood-2008-07-168617.
19.
LuesinkMJansenJH. Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia. Br J Haematol2010;151(3):209–20 doi: 10.1111/j.1365–2141.2010.08325.x.
20.
SanzMAGrimwadeDTallmanMSLowenbergBFenauxPEsteyEH. Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood2009; 113(9):1875–91 doi: 10.1182/blood-2008-04-15025.
